Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Overview of Metabolomics
- Separation Techniques
- Detection Techniques
- Metabolites and Their Applications
- R&D and Regulatory Approval
- Supply Chain Analysis
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Technological Advancements
- Increasing Healthcare Expenditure
- Expanding Applications Across Industries
- Market Restraints
- High Cost of Instruments and Services
- Complexity of Data Analysis
- Standardization and Quality Control Challenges
- Limited Biomarker Validation and Clinical Utility
- Market Opportunities
- Precision Medicine and Personalized Healthcare
- Drug Discovery and Development
- Biomarker Discovery and Validation
- Nutritional Profiling and Functional Foods
- Environmental Monitoring and Toxicology
- Market Challenges
- Data Complexity and Interpretation
- Standardization and Quality Assurance
- Biomarker Validation and Clinical Translation
- Technological Limitations and Costs
- Regulatory and Ethical Considerations
Chapter 4 Emerging Technologies and Developments
- Introduction
- Clinical Trial Analysis
- By Study Type
- By Status
- By Gender
- By Interventions
- Granted Patents
- Introduction
- Patent Analysis
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Metabolomics Market, by Product
- Global Market Analysis and Forecast
- Separation Techniques
- Detection Techniques
- Metabolomics Market, by Indication
- Global Market Analysis and Forecast
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Other Diseases Indication
- Metabolomics Market, by Application
- Global Market Analysis and Forecast
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Others
- Geographic Breakdown
- Metabolomics Market, by Region
- Global
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Company Share Analysis
- Strategic Analysis
- Mergers and Acquisitions
- Venture Capital Funding
List of Tables
Summary Table: Global Market for Metabolomics Technologies, by Product, Through 2029
Table 1: Publications Referencing Metabolomics, 2021-2023
Table 2: Mass Spectrometry Products from Different Global Players
Table 3: Prices of Mass Spectrometry Products from Different Global Players
Table 4: Mass Spectrometry Steps to Metabolite Identification
Table 5: Various Metabolites and Their Functions and Applications
Table 6: Metabolomics Supply Chain
Table 7: Metabolomics Supply Chain Examples
Table 8: List of Bioinformatics Tools Used in Metabolomics
Table 9: List of Biomarkers Used in the Metabolomics and Applications
Table 10: Global Regulatory and Ethical Considerations for Metabolomics-Based Products
Table 11: Metabolomics Emerging Technologies
Table 12: Selected Clinical Trials Data for Metabolomics, 2021-2024
Table 13: Selected Granted Patents of Metabolomics, 2022 and 2023
Table 14: Global Market for Metabolomics Technologies, by Product, Through 2029
Table 15: Global Market for Separation Techniques in Metabolomics Technologies, by Region, Through 2029
Table 16: Global Market for Detection Techniques in Metabolomics Technologies, by Region, Through 2029
Table 17: Global Market for Metabolomics Technologies, by Disease Indication, Through 2029
Table 18: Global Market for Metabolomics Technologies for Cancer Indication, by Region, Through 2029
Table 19: Global Market for Metabolomics Technologies for Cardiovascular Disorders, by Region, Through 2029
Table 20: Global Market for Metabolomics Technologies for Neurological Disorders, by Region, Through 2029
Table 21: Global Market for Metabolomics Technology for Inborn Errors of Metabolism, by Region, Through 2029
Table 22: Global Market for Metabolomics Technologies for Other Diseases Indication, by Region, Through 2029
Table 23: Global Market for Metabolomics Technologies, by Application, Through 2029
Table 24: Global Market for Metabolomics Technologies in Biomarker Discovery, by Region, Through 2029
Table 25: Global Market for Metabolomics Technologies in Drug Discovery, by Region, Through 2029
Table 26: Global Market for Metabolomics Technologies in Toxicology Testing, by Region, Through 2029
Table 27: Global Market for Metabolomics Technologies in Nutrigenomics, by Region, Through 2029
Table 28: Global Market for Metabolomics Technologies in Functional Genomics, by Region, Through 2029
Table 29: Global Market for Metabolomics Technologies in Other Applications, by Region, Through 2029
Table 30: Global Market for Metabolomics Technologies, by Region, Through 2029
Table 31: North American Market for Metabolomics Technologies, by Country, Through 2029
Table 32: European Market for Metabolomics Technologies, by Country, Through 2029
Table 33: Asia-Pacific Market for Metabolomics Technologies, by Country, Through 2029
Table 34: Rest of the World Market for Metabolomics Technologies, Through 2029
Table 35: Merger and Acquisitions in the Global Market for Metabolomics Technologies, 2023
Table 36: Funded Projects for Metabolomics Technologies, 2021-2024
Table 37: Report Sources
Table 38: Major Acronyms Used in This Report
Table 39: Agilent Technologies Inc.: Company Snapshot
Table 40: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 41: Agilent Technologies Inc.: Product Portfolio
Table 42: Agilent Technologies Inc.: News/Key Developments, 2023 and 2024
Table 43: Bio-Rad Laboratories Inc.: Company Snapshot
Table 44: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 45: Bio-Rad Laboratories Inc.: Product Portfolio
Table 46: Bio-Rad Laboratories Inc.: News/Key Developments, 2023 and 2024
Table 47: Bruker: Company Snapshot
Table 48: Bruker: Financial Performance, FY 2022 and 2023
Table 49: Bruker: Product Portfolio
Table 50: Bruker: News/Key Developments, 2023
Table 51: Danaher Corp.: Company Snapshot
Table 52: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 53: Danaher Corp.: Product Portfolio
Table 54: Danaher Corp.: News/Key Developments, 2023 and 2024
Table 55: Merck KGaA: Company Snapshot
Table 56: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 57: Merck KGaA: Product Portfolio
Table 58: Merck KGaA: News/Key Developments, 2023
Table 59: Shimadzu Corp.: Company Snapshot
Table 60: Shimadzu Corp.: Financial Performance, FY 2021 and 2022
Table 61: Shimadzu Corp.: Product Portfolio
Table 62: Shimadzu Corp.: News/Key Developments, 2023
Table 63: Thermo Fisher Scientific Inc.: Company Snapshot
Table 64: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 65: Thermo Fisher Scientific Inc.: Product Portfolio
Table 66: Thermo Fisher Scientific Inc.: News/Key Developments, 2023
Table 67: Waters Corp.: Company Snapshot
Table 68: Waters Corp.: Financial Performance, FY 2022 and 2023
Table 69: Waters Corp.: Product Portfolio
Table 70: Waters Corp.: News/Key Developments, 2023
List of Figures
Summary Figure: Global Market for Metabolomics Technologies, by Product, 2024-2029
Figure 1: Publications Referencing Metabolomics, 2021-2023
Figure 2: Different Metabolomics Techniques
Figure 3: Schematic Diagram of Mass Spectrometry
Figure 4: Market Dynamics of Global Metabolomics Technologies
Figure 5: Global Healthcare Expenditure, 2021-2023
Figure 6: Global Shares of Metabolomics Clinical Trials, by Study, 2024
Figure 7: Global Shares of Metabolomics Clinical Trials, by Status, 2024
Figure 8: Global Shares of Metabolomics Clinical Trials, by Gender, 2024
Figure 9: Global Metabolomics Clinical Trials, by Interventions, 2024
Figure 10: Selected Granted Patents Involving Metabolomics, by Applicant, 2022 and 2023
Figure 11: Global Market Shares of Metabolomics Technologies, by Product, 2023
Figure 12: Global Market Shares of Metabolomics Technologies, by Disease Indication, 2023
Figure 13: Global Market Shares of Metabolomics Technologies, by Application, 2023
Figure 14: Global Market Shares of Metabolomics Technologies, by Region, 2023
Figure 15: North American Market Shares of Metabolomics Technologies, by Country, 2023
Figure 16: European Market Shares of Metabolomics Technologies, by Country, 2023
Figure 17: Asia-Pacific Market Shares of Metabolomics Technologies, by Country, 2023
Figure 18: Global Market Shares of Metabolomics Technologies, by Company, 2023
Figure 19: Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 20: Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 21: Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 22: Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 23: Bruker: Revenue Shares, by Business Unit, FY 2023
Figure 24: Bruker: Revenue Shares, by Country/Region, FY 2023
Figure 25: Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 26: Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 27: Merck KGaA: Revenue Shares, by Business Unit, FY 2023
Figure 28: Merck KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 29: Shimadzu Corp.: Revenue Shares, by Business Unit, FY 2022
Figure 30: Shimadzu Corp.: Revenue Shares, by Country/Region, FY 2022
Figure 31: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 32: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 33: Waters Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 34: Waters Corp.: Revenue Shares, by Country/Region, FY 2023
